New Page 1
 

COPD-X Menu
COPD-X Menu COPD-X Home Page COPD-X Guidelines Management Tools Case Statements News & Resources COPD Institute Contact Us
COPD-X Menu

 

Refs 201-2250

References 201 - 250

Refs 1 - 50 Refs 51 - 100 Refs 101 - 150 Refs 151 - 200 Refs 201 - 250 Refs 251 - 286
Note: [return to text] - goes to the last page in viewed in COPD-X regardless of reference number.
 
201 Celli BR. Pulmonary rehabilitation in patients with COPD. Am J Respir Crit Care Med. 1995 Sep;152(3):861-4.
202 Pulmonary rehabilitation-1999. American Thoracic Society. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1666-82.
203 Fishman AP. Pulmonary rehabilitation research. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):825-33.
204 Mathers C, Vos T, Stevenson C. The Burden of Disease and Injury in Australia. Canberra: Australian Institute of Health and Welfare 1999.
205 Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007 Mar 26;167(6):551-61.
206 Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet. 1996;348(9035):1115-9.
207 Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Randomised controlled trial of respiratory rehabilitation. Lancet. 1994 Nov 19;344(8934):1394-7.
208 O'Donnell DE, McGuire M, Samis L, Webb KA. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2005-13.
209 Lake FR, Henderson K, Briffa T, Openshaw J, Musk AW. Upper-limb and lower-limb exercise training in patients with chronic airflow obstruction. Chest. 1990 May;97(5):1077-82.
210 Ries AL, Ellis B, Hawkins RW. Upper extremity exercise training in chronic obstructive pulmonary disease. Chest. 1988 Apr;93(4):688-92.
211 Martinez FJ, Vogel PD, Dupont DN, Stanopoulos I, Gray A, Beamis JF. Supported arm exercise vs unsupported arm exercise in the rehabilitation of patients with severe chronic airflow obstruction. Chest. 1993 May;103(5):1397-402.
212 Covey MK, Larson JL, Wirtz SE, Berry JK, Pogue NJ, Alex CG, et al. High-intensity inspiratory muscle training in patients with chronic obstructive pulmonary disease and severely reduced function. J Cardiopulm Rehabil. 2001 Jul-Aug;21(4):231-40.
213 Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J. 1999 Jan;13(1):125-32.
214 Young P, Dewse M, Fergusson W, Kolbe J. Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme. Aust N Z J Med. 1999 Feb;29(1):59-65.
215 McGavin CR, Gupta SP, Lloyd EL, McHardy GJ. Physical rehabilitation for the chronic bronchitic: results of a controlled trial of exercises in the home. Thorax. 1977 Jun;32(3):307-11.
216 Wedzicha JA, Bestall JC, Garrod R, Garnham R, Paul EA, Jones PW. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J. 1998 Aug;12(2):363-9.
217 Mahler DA. Pulmonary rehabilitation. Chest. 1998 Apr;113(4 Suppl):263S-8S.
218 Putting prevention into practice: Guidelines for the implementation of prevention in the general practice setting (The Green Book). 1st ed. Melbourne: The Royal Australian College of General Practitioners, 1998.
219 Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med. 2006 Oct;100(10):1767-74.
220 Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000(3):CD000336.
221 Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003 Mar 10;163(5):585-91.
222 Shepperd S, Harwood D, Gray A, Vessey M, Morgan P. Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis. Bmj. 1998 Jun 13;316(7147):1791-6.
223 Shepperd S, Harwood D, Jenkinson C, Gray A, Vessey M, Morgan P. Randomised controlled trial comparing hospital at home care with inpatient hospital care. I: three month follow up of health outcomes. Bmj. 1998 Jun 13;316(7147):1786-91.
224 Celli BR. Current thoughts regarding treatment of chronic obstructive pulmonary disease. Med Clin North Am. 1996 May;80(3):589-609.
225 Turnock AC, Walters EH, Walters JA, Wood-Baker R. Action plans for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005(4):CD005074.
226 Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. Bmj. 2003 Sep 6;327(7414):523-8.
227 Geelhoed EA, Brameld KJ, Holman CD, Thompson PJ. Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends. Intern Med J. 2007 Feb;37(2):87-94.
228 Ansari Z, Dunt D, Dharmage SC. Variations in hospitalizations for chronic obstructive pulmonary disease in rural and urban Victoria, Australia. Respirology. 2007 Nov;12(6):874-80.
229 Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet. 1993 Feb 27;341(8844):511-4.
230 Smith CB, Kanner RE, Golden CA, Klauber MR, Renzetti AD, Jr. Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis. 1980 Mar;141(3):271-80.
231 Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1498-505.
232 Wilson R. The role of infection in COPD. Chest. 1998 Apr;113(4 Suppl):242S-8S.
233 Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest. 2000 Jun;117(6):1638-45.
234 Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med. 1999 Sep;160(3):791-5.
235 Mogulkoc N, Karakurt S, Isalska B, Bayindir U, Celikel T, Korten V, et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med. 1999 Jul;160(1):349-53.
236 Murphy TF, Sethi S, Klingman KL, Brueggemann AB, Doern GV. Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. J Infect Dis. 1999 Aug;180(2):404-9.
237 Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest. 1999 Jul;116(1):40-6.
238 Anderson HR, Spix C, Medina S, Schouten JP, Castellsague J, Rossi G, et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J. 1997 May;10(5):1064-71.
239 Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004 Jun 15;169(12):1298-303.
240 Skwarska E, Cohen G, Skwarski KM, Lamb C, Bushell D, Parker S, et al. Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax. 2000 Nov;55(11):907-12.
241 Kong GK, Belman MJ, Weingarten S. Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. Chest. 1997 Jan;111(1):89-94.
242 Ram FS, Wedzicha JA, Wright J, Greenstone M. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2003(4):CD003573.
243 BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax. 1997;52(Suppl 5):S1-S28.
244 Moayyedi P, Congleton J, Page RL, Pearson SB, Muers MF. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. Thorax. 1995 Aug;50(8):834-7.
245 Fernandez A, Munoz J, de la Calle B, Alia I, Ezpeleta A, de la Cal MA, et al. Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med. 1994;20(3):199-202.
246 McCrory DC, Brown CD. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002(4):CD003900.
247 Turner MO, Patel A, Ginsburg S, FitzGerald JM. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med. 1997 Aug 11-25;157(15):1736-44.
248 Stoller JK. Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002 Mar 28;346(13):988-94.
249 Barbera JA, Reyes A, Roca J, Montserrat JM, Wagner PD, Rodriguez-Roisin R. Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease. American Rev Respir Dis. 1992 Jun;145(6):1328-33.
250 Murciano D, Aubier M, Lecocguic Y, Pariente R. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med. 1984 Aug 9;311(6):349-53.

Next Page Previous Page